Followers | 170 |
Posts | 9931 |
Boards Moderated | 3 |
Alias Born | 06/20/2022 |
Friday, December 09, 2022 10:16:17 AM
Recent PHVS News
- Pharvaris Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update • GlobeNewswire Inc. • 04/10/2024 08:10:00 PM
- Pharvaris Appoints David Nassif, J.D., as Chief Financial Officer • GlobeNewswire Inc. • 04/10/2024 08:08:00 PM
- Pharvaris to Present Deucrictibant Clinical Data at the CIIC Spring 2024 Conference • GlobeNewswire Inc. • 04/04/2024 10:50:00 AM
- Pharvaris Announces Phase 3 Clinical Study Design for Recently Initiated RAPIDe-3 Study, and Presents Quality-of-Life Improvement and Caregiver Behavior Data at Two Recent HAE Congresses • GlobeNewswire Inc. • 03/18/2024 10:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/11/2024 05:51:18 PM
- Form F-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/06/2024 09:40:58 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2024 09:15:02 PM
- Pharvaris to Present Deucrictibant Clinical Data at Upcoming Congresses • GlobeNewswire Inc. • 03/06/2024 11:50:00 AM
- Pharvaris to Participate in the Leerink Global Biopharma Conference 2024 • GlobeNewswire Inc. • 03/05/2024 11:50:00 AM
- Positive Results from CHAPTER-1 Phase 2 Study of Deucrictibant for the Prophylactic Treatment of HAE Attacks to be Presented at AAAAI 2024 Annual Meeting • GlobeNewswire Inc. • 02/22/2024 11:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/16/2024 11:51:04 AM
- Pharvaris Announces Extraordinary Meeting of Shareholders • GlobeNewswire Inc. • 02/16/2024 11:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/07/2024 09:01:03 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/01/2024 09:46:17 PM
- Pharvaris to Present at the WSAAI Annual Meeting 2024 • GlobeNewswire Inc. • 01/26/2024 11:50:00 AM
- Pharvaris Says FDA Lifted Clinical Hold on Application for Deucrictibant • Dow Jones News • 01/22/2024 12:35:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/22/2024 11:51:43 AM
- Pharvaris Announces FDA Lifting of the Clinical Hold of Deucrictibant for the Prophylactic Treatment of HAE Attacks • GlobeNewswire Inc. • 01/22/2024 11:50:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 12:00:42 PM
- Pharvaris Provides Business Update and Outlines 2024 Strategic Priorities • GlobeNewswire Inc. • 01/05/2024 11:50:00 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 01/02/2024 09:29:13 PM
- Pharvaris Presents Deucrictibant Clinical Data and Analysis of Endpoints for Trials of On-demand Treatment of HAE at the GA²LEN UCARE Conference 2023 • GlobeNewswire Inc. • 12/08/2023 11:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/08/2023 09:50:30 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 12/07/2023 09:17:02 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 12/06/2023 09:36:40 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM